Sitagliptin: the fixed combination of the first dipeptidyl peptidase 4 inhibitor and metformin

L. V. Egshatyan

Meditsinskiy sovet = Medical Council
Meditsinskiy sovet

ISSN 2079-701X (Print)
ISSN 2658-5790 (Online)

User

eng | рус

Meditsinskiy sovet = Medical Council

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Egshatyan LV. Sitagliptin: the fixed combination of the first dipeptidyl peptidase 4 inhibitor and metformin. Meditsinskiy sovet = Medical Council. 2023;(13):116-121. (In Russ.) https://doi.org/10.21518/ms2023-168

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2079-701X (Print)
ISSN 2658-5790 (Online)

Editor-in-Chief

Aydar A. Ishmukhametov

* not an advertisement

По рекомендации Президиума ВАК от 8 декабря 2023 г. № 31/1-разн

"О категорировании перечня рецензируемых научных изданий, в которых должны быть опубликованы основные научные результаты диссертаций на соискание ученой степени кандидата наук, на соискание ученой степени доктора наук" журналу «Медицинский совет» присвоена категория К1

Popular articles

Indexing Databases

* not an advertisement

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Author

L. V. Egshatyan
Yevdokimov Moscow State University of Medicine and Dentistry; Loginov Moscow Clinical Scientific Center
Russian Federation

Lilit V. Egshatyan - Cand. Sci. (Med.), Endocrinologist, Assistant of the Department of Endocrinology and Diabetology of the Medical Faculty, Yevdokimov MSU of Medicine and Dentistry; Senior Researcher of Department of Endocrinology, Loginov MClSC.

20, Bldg. 1, Delegatskaya St., Moscow, 127473; 86, Entuziastov Shosse, Moscow, 111123

Notifications

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Meditsinskiy sovet = Medical Council

For citations:

Cookies policy